Auburn National Bancorporation heads into the week after a stronger-than-expected Q1 print — yet the stock has drifted lower, leaving a gap between fundamental improvement and price action that is worth examining.
The earnings story is genuinely positive. Q1 EPS came in at $0.63, up 43% from $0.44 a year ago, on revenue of $8.6 million versus $7.8 million. Net income rose to $2.2 million from $1.5 million. The print was filed April 28 and confirmed ahead of a previously scheduled May 1 reporting date. Despite that, the stock fell 2% on the week to $23.51, extending a near-2% decline over the past month. The market's tepid response to a meaningful profit jump is the week's central tension.
Short interest is a negligible factor here. At just 0.21% of the free float — roughly 7,200 shares — there is no meaningful bear position to speak of. That figure has actually declined about 23% over the past week, continuing a broader pullback from an April 20 peak near 9,300 shares. The borrow market reflects the same indifference: availability is wide open, with lending pool utilisation running well under 1%, near the lowest levels of the past year and far from the 52-week high of 4.5%. Cost to borrow has nudged up about 22% over the past month to 4.1% — still low in absolute terms — but that move reflects general micro-cap borrow dynamics rather than any targeted short campaign. The ORTEX short score has dropped sharply this week, falling from 33.2 on April 20 to 27.8 on April 28, ranking in the 76th percentile on a sector-relative basis but pointing in the right direction.
The ownership picture reflects the stock's concentrated, insider-heavy nature. The top four holders — Emil Wright, Anne May, Sandra Spencer, and Bruce Spencer — collectively own roughly 34% of shares outstanding, with none of them having changed positions materially since their last reported dates. Among institutional holders, Vanguard added 3,710 shares to reach 80,269 as of March 31, while Truffle Hound Capital and Bridgeway Capital each added modest positions at year-end 2025. Director Walton Conn has been a consistent small buyer since late January, accumulating shares across six separate transactions at prices between $24.10 and $25.40 — all above the current $23.51 close. The CEO and CFO both sold small lots in March at $23.85, but the values involved (under $5,000 each) carry little informational weight. The net insider position over the past 90 days is marginally positive at roughly $26,500 net bought, driven entirely by Conn's steady accumulation.
Historical earnings reactions for AUBN have been modest in both directions. The Q4 2025 print (reported January 30) produced a 3.5% decline the next day and a 3% slide over the following week. The Q3 2025 result saw just under a 1% one-day gain but faded slightly by the five-day mark. The pattern suggests the stock rarely makes dramatic post-earnings moves. This quarter's 2% weekly decline, against a strong profit beat, sits in that same measured range — market participants are pricing in the result without much excitement.
What to watch next: the Q2 2026 earnings date is pencilled in for July 24, according to S&P Global's current estimate. Between now and then, whether Conn continues buying below $24 and how the stock handles the gap between its insider-level entry prices and the current drift lower will tell most of the story worth telling on this name.
See the live data behind this article on ORTEX.
Open AUBN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
